Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Garran
Clinical trial register · Australia

Clinical Trials in Garran, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Garran

77 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Incyte Corporation
Phase 3
426
Blacktown, Gosford, Liverpool, Birtinya, Brisbane, Melbourne, Cooloongup, Garran
2026-09-08
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
SystImmune Inc.
Phase 3
550
Garran, Southport, Bedford Park
2026-08-04
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
2026-05-31
Recruiting
AstraZeneca
Phase 3
2,130
Darlinghurst, Garran, Heidelberg, Murdoch, Randwick, Westmead, Woolloongabba
2026-02-03
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Liverpool, St Leonards, Birtinya, Brisbane, Elizabeth Vale, Hobart, Ballarat Central, Garran
2026-01-02
Recruiting
AstraZeneca
Phase 3
1,100
Adelaide, Auchenflower, Campbelltown, Camperdown, Clayton, Cudgen, Garran, Gosford
2025-12-29
Recruiting
GlaxoSmithKline
Phase 3
450
Garran, Camperdown, Westmead, Melbourne
2025-12-03
Recruiting
Eli Lilly and Company
Phase 3
7,140
Adelaide, Blacktown, Box Hill, Brisbane, Bruce, Camberwell, Frankston, Garran
2025-12-01
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Garran, Clayton
2025-10-03
Recruiting
Amgen
Phase 3
11,000
Garran, Camperdown, Charlestown, Concord, Merewether, Orange, Wollongong, Auchenflower
2025-08-22
Recruiting
Takeda
Phase 3
150
Garran, Concord, Kogarah, Liverpool, Westmead, Melbourne, Murdoch, West Perth
2025-08-14
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Garran, Blactown, Burwood, Camperdown, Concord, Liverpool, New Lambton Heights, St Leonards
2025-07-22
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
AstraZeneca
Phase 3
990
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
2025-03-25
Recruiting
ROADMAP Clinical Trial
NCT06771050Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
University of Newcastle, Australia
Phase 4
2,500
Garran, Bankstown, Blacktown, Campbelltown, Camperdown, Caringbah, Gateshead, Kingswood
2025-03-24
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Recruiting
Takeda
Phase 3
171
Garran, Concord, Kogarah, Liverpool, Westmead, Melbourne, Murdoch, West Perth
2025-02-27
Recruiting
Rigicon, Inc.
Not applicable
182
Auchenflower, Garran, Hornsby, Hurstville, Malvern, Miranda, Moorabbin
2025-01-16
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Garran, Camperdown, Westmead, Chermside, Adelaide, Heidelberg, Melbourne, Murdoch
2024-09-26
Active, closed
Hoffmann-La Roche
Phase 3
400
Garran, Sydney, South Brisbane, Adelaide, Murdoch
2024-09-17
Recruiting
The George Institute
Phase 3
2,000
Garran, Kingswood, Kogarah, New Lambton Heights, Westmead, Birtinya, Douglas, Ipswich
2024-09-04
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Ballarat, Bendigo, Birtinya, Brisbane, Camperdown, Clayton, Concord, Garran
2024-08-30
Recruiting
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
69
Garran, Albury, Darlinghurst, St Leonards, Wahroonga, Chermside, South Brisbane, Adelaide
2024-08-14
Recruiting
AstraZeneca
Phase 3
1,018
Clayton, Darlinghurst, Garran, Heidelberg, Macquarie University, Nedlands
2024-08-07
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Garran, Concord, Gosford, Kingswood, Kotara, Brisbane, Chermside, Tugun
2024-06-17
Active, closed
Eli Lilly and Company
Phase 3
10,000
Adelaide, Botany, Box Hill, Brisbane, Brookvale, Camberwell, Garran, Geelong
2024-04-30
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Garran, Heidelberg, Melbourne, Murdoch
2023-12-20
Recruiting
Intellia Therapeutics
Phase 3
1,200
Garran, Westmead, Cairns, Box Hill, Perth, Adelaide, Melbourne, Woolloongabba
2023-12-13
Active, closed
Novartis Pharmaceuticals
Phase 2
41
Garran, Melbourne
2023-08-16
Active, closed
Swedish Orphan Biovitrum
Observational
165
Liverpool, Waratah, Birtinya, Garran
2023-06-26
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Garran, Camperdown, Caringbah, Darlinghurst, Gosford, Kingswood, Orange, Saint Leonards
2023-04-26
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Adelaide, Brisbane, Concord, Frankston, Garran, Herston, Joondalup, Kotara
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Garran, Camperdown, Concord, Auchenflower, Sippy Downs, Woolloongabba, Adelaide, Leabrook
2023-03-09
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Garran, Wooloongabba, Clayton, Melbourne
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Garran, Melbourne
2022-12-30
Active, closed
Amgen
Phase 3
7,297
Garran, Camperdown, Concord, Liverpool, Sydney, Wollongong, Auchenflower, Bundaberg
2022-12-14
Recruiting
Monash University
Phase 2/3
300
Garran, Concord, St Leonards, Clayton, Heidelberg, Melbourne, St Albans
2022-11-30
Active, closed
GlaxoSmithKline
Phase 3
110
Garran
2022-09-06
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
Panbela Therapeutics, Inc.
Phase 2/3
600
Garran, Tweed Heads, Kurralta Park, Heidelberg, Murdoch
2022-08-08
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Garran, Waratah
2022-04-15
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Garran, Concord, Kogarah, New Lambton Heights, Saint Leonards, Adelaide, Fitzroy, St Albans
2022-04-05
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Garran, Concord, Kogarah, Liverpool, New Lambton Heights, Randwick, Saint Leonards, Adelaide
2022-03-15
Recruiting
University of Melbourne
Phase 4
8,000
Garran, Blacktown, Camperdown, Concord, Darlinghurst, Kingswood, Kogarah, Liverpool
2022-02-16
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Woolloongabba, Melbourne, Garran
2021-11-30
Active, closed
argenx
Phase 3
173
Garran, West Perth, Westmead
2021-11-17
Active, closed
Amgen
Phase 3
303
Garran, Camperdown, Liverpool, St Leonards, Westmead, Herston, Woolloongabba, Adelaide
2021-11-02
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Adelaide, Ballarat, Chermside, Clayton, Concord, Epping, Garran, Gosford
2021-08-14
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Bedford Park, Clayton, Garran, Heidelberg, Melbourne, Waratah
2021-06-24
Active, closed
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
617
Garran, Adelaide, Melbourne, Parkville
2021-06-01
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Garran, Darlinghurst, Kogarah, Liverpool, Wentworthville, Melbourne, Perth
2021-03-09
Recruiting
Saluda Medical Pty Ltd
Not applicable
200
Garran, Bella Vista, Broadmeadow, Charlestown, Hurstville, Newtown, Saint Leonards, St Leonards
2020-12-15
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ballarat, Bedford Park, Clayton, Garran, Hyde Park, Port Macquarie, Wollongong, Woolloongabba
2020-12-02
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
GlaxoSmithKline
Phase 3
302
Garran, Darlinghurst, Gosford NSW, Port Macquarie, Benowa, South Brisbane, Adelaide, Fitzroy
2020-10-01
Recruiting
Nordic Lymphoma Group
Phase 3
300
Albury, Camperdown, Coffs Harbour, Concord, Cudgen, Garran, Hobart, Liverpool
2020-08-19
Recruiting
University of Leicester
Not applicable
2,104
Garran, Liverpool, St Leonards, Westmead, Wollongong, Chermside, Douglas, Southport
2020-03-10
Recruiting
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Bruce, Garran, Sydney, Brisbane, Gold Coast, Adelaide, Melbourne
2019-12-17
Active, closed
BeOne Medicines
Phase 3
510
Garran, Concord, Cudgen, Darlinghurst, Gosford, Waratah, Birtinya, South Brisbane
2019-08-20
Active, closed
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
NCT07224347Functional Disability, Dementia, Heart Disease, Stroke
Anne Murray
Observational
19,114
Garran, Wollongong, Adelaide, Mount Gambier, Burnie, Hobart, Launceston, Bendigo
2019-07-15
Recruiting
Population Health Research Institute
Phase 4
2,270
Garran, Bankstown, Camperdown, Concord, Liverpool, Newcastle, Westmead, Birtinya
2019-06-14
Active, closed
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Clayton, Darlinghurst, Garran, Melbourne, Nedlands, South Brisbane, Waratah, Westmead
2017-06-21
Active, closed
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
NCT01320345Type 1 Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathies
University of Sydney
Phase 3
412
Garran, Camperdown, Concord, Darlinghurst, Liverpool, Merewether, Randwick, Saint Leonards
2016-11-03
Recruiting
Western Sydney Local Health District
Not applicable
1,058
Garran, Kingswood, New Lambton Heights, Randwick, Saint Leonards, Westmead, Wollongong, Birtinya
2014-02-27
Active, closed
AbbVie
Observational
8,250
Garran, Camperdown, Concord, East Lismore, New Lambton, Herston, South Brisbane, Adelaide
2013-04-29
Active, closed
Eli Lilly and Company
Phase 2
110
Garran, Wodonga, Perth
2012-05-22
Rows per page Showing 1–77 of 77
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/garran

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 77 of those studies with a site in Garran.

How many clinical trials are recruiting in Garran?

42 of the 77 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 32 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Garran), 77 studies
PhaseStudiesRecruitingShare
Phase 3482262.3%
Phase 2/38710.4%
Not applicable759.1%
Phase 2637.8%
Observational415.2%
Phase 4333.9%
Phase 1/2111.3%

Most active sponsors

Lead sponsors with the most studies (Garran)
Lead sponsorStudiesRecruiting
AstraZeneca55
Novartis Pharmaceuticals51
AbbVie42
Amgen42
Boehringer Ingelheim43
Eli Lilly and Company31
GlaxoSmithKline31
Takeda33
BeOne Medicines21
Hoffmann-La Roche21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.